Drug Information Related to Panretin
Back
01. Ligand Announces Sale of Oncology Product Lines as Next Step in ......
SAN DIEGO -- Ligand ligand /li·gand/ (li´gand) (lig´and) an organic molecule that donates the necessary electrons to form coordinate covalent bonds with metallic ions. Also, an ion or molecule that reacts to form a complex with another molecule. Pharmace...
02. LIGAND SUBMITS MAA FOR ONZAR IN EUROPE. - Free Online Library
Ligand ligand /li·gand/ (li´gand) (lig´and) an organic molecule that donates the necessary electrons to form coordinate covalent bonds with metallic ions. Also, an ion or molecule that reacts to form a complex with another molecule. Pharmaceuticals Incor...
03. Ligand Presents Data on Novel RXR Homodimer Antagonist Compound with ....
Business Editors/Health and Medical Writers BIOWIRE2K SAN DIEGO--(BW HealthWire)--Feb. 18, 2000 Ligand ligand /li·gand/ (li´gand) (lig´and) an organic molecule that donates the necessary electrons to form coordinate covalent bonds with metallic ions. Also,...
04. Eisai Acquires Four Oncology-Related Products from Ligand. - Free ......
Tokyo, Japan, Sept 8, 2006 - (JCN) - Eisai has announced that it signed a product acquisition agreement with California-based Ligand Pharmaceuticals for exclusive global rights for their four oncology-related products, ONTAK (denileukin diftitox denileukin diftitox&n...
05. Approved Drugs for HIV/AIDS or AIDS-related Conditions. - Free Online ...
July 6, 1999 * Abacavir abacavir /abac·a·vir/ (ah-bak´ah-vir) a nonnucleoside reverse transcriptase inhibitor used as the sulfate salt as an antiretroviral in the treatment of human immunodeficiency virus infection. (Ziagen), Glaxo Wellcome Approved De...
06. Ligand Reports Record Financial Results for Full Year and Fourth ......
Business Editors & Health/Medical WritersBIOWIRE2KSAN DIEGO--(BW HealthWire)--March 11, 2002Fourth Quarter Operating Loss Down 73% Versus Prior Year; LigandSelects Avinza(TM) as Brand Name for Morphelan(TM)Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today r...
07. Targretin Increases Susceptibility of Leukemic B- and T-Cells to ONTAK...
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--(BUSINESS WIRE)--Aug. 29, 2002 Rexinoids Modulate Immune Response in CLL and Sezary Cells Treating leukemic B- and T-cells with Ligand's (Nasdaq: LGND) bexarotene bexarotene /bex·ar·o·tene...
08. Ligand Receives FDA Marketing Clearance for Panretin Gel for Treatment...
SAN DIEGO--(BUSINESS WIRE)--Feb. 3, 1999-- Panretin Gel Ligand's First Commercial Product Ligand Pharmaceuticals Incorporated (Nasdaq: LGND; pronounced LYE-gand Gand: see Ghent, Belgium.) announced today that the U.S. Food and Drug Administration (FDA) has gra...
09. Studies Presented At 12th International AIDS Conference Support ......
GENEVA, Switzerland--(BW HealthWire)--June 30, 1998-- Up to 50 Percent of Patients Studied Experienced Clearing/Reduction of Lesions; Tumor Reduction Observed Independent of Concurrent Antiretroviral Therapy Scientists participating in the 12th International...
10. Four Clinical Trials Presented at AAD Show Ligand's Targretin, Panreti...
Business Editors/Health/Medical Writers
...
11. Data Presented At AAD Show Low Doses of ONTAK Induce Responses in ......
Business Editors & Health/Medical Writers
...
12. Ligand AIDS drug gets FDA advisory panel clearance | Drug Store News ....
An FDA advisory panel recommended approval of Ligand Pharmaceuticals' first product, Panretin gel for treating skin lesions associated with AIDS-related Kaposi's sarcoma. However, the panel said it wouldn't recommend classifying the drug as a primary treatment, the ap...
13. Ligand and Parke-Davis Enter into Research Collaboration | Business .....
SAN DIEGO--(BW HealthWire)--Sept. 1, 1999--
...
14. Approved Drugs for HIV/AIDS or AIDS-related Conditions - Pamphlet ......
July 6, 1999
...
